CLARIVATE PLC

Clarivate expands agentic AI across Cortellis, speeding drug‑discovery, safety assessment, and competitive intelligence for life‑sciences R&D.

Clarivate’s new IPOne platform blends AI agents with proprietary IP data, enabling smarter discovery, clearance, and monitoring for law firms and corporate IP teams.

Clarivate PLC has announced a leadership change, appointing Maroun S. Mourad as President of its Intellectual Property segment, and reported Q2 2025 results with a decline in revenue but reaffirmed 2025 outlook and confidence in its financial strate…

Clarivate PLC reported a 4.5% decrease in total revenues for Q1 2025, but still exceeded earnings and revenue estimates, reaffirming its 2025 outlook and announcing a $50 million share repurchase.

Clarivate PLC reported a mixed bag of first quarter 2025 results, with a decline in total revenues but a 0.3% increase in organic revenue growth, driven by a 0.6% rise in organic recurring revenues.

Clarivate PLC reported a net loss of $103.9 million in Q1 2025, but reaffirmed its outlook and took strategic steps to strengthen its market position, including a $50 million share repurchase.